These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 5336046)

  • 1. Sernyl, ditran, and their antagonists: succinate and THA.
    Neubauer H; Sundland DM; Gershon S
    Int J Neuropsychiatry; 1966 Jun; 2(3):216-22. PubMed ID: 5336046
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical and polygraphic study of a drug with psychodysleptic properties: Ditran].
    Giovannucci M; Marforio S; Morlotti PA
    Riv Sper Freniatr Med Leg Alien Ment; 1967 Apr; 91(2):555-68. PubMed ID: 6081348
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical Therapeutic Conference: dopaminergic/serotonergic actions of phencyclidine as a model for schizophreniform psychosis.
    Gabbert JF; Giannini AJ
    Am J Ther; 1997 Apr; 4(4):159-63. PubMed ID: 10423606
    [No Abstract]   [Full Text] [Related]  

  • 4. PCP: from pharmacology to modelling schizophrenia.
    Morris BJ; Cochran SM; Pratt JA
    Curr Opin Pharmacol; 2005 Feb; 5(1):101-6. PubMed ID: 15661633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ditran and its antagonists in a mixed psychiatric population.
    Neubauer H; Sundland D; Gershon S
    J Nerv Ment Dis; 1966 Mar; 142(3):265-77. PubMed ID: 5936310
    [No Abstract]   [Full Text] [Related]  

  • 6. Anticholinergic drug-induced delirium: experimental modification, quantitative EEG and behavioral correlations.
    Itil T; Fink M
    J Nerv Ment Dis; 1966 Dec; 143(6):492-507. PubMed ID: 5964304
    [No Abstract]   [Full Text] [Related]  

  • 7. Bipolar disorder, schizoaffective disorder, and schizophrenia overlap: a new comorbidity index.
    Laursen TM; Agerbo E; Pedersen CB
    J Clin Psychiatry; 2009 Oct; 70(10):1432-8. PubMed ID: 19538905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating the association between neurocognition and psychosis in bipolar disorder: further evidence for the overlap with schizophrenia.
    Jabben N; Arts B; Krabbendam L; van Os J
    Bipolar Disord; 2009 Mar; 11(2):166-77. PubMed ID: 19267699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential working memory impairment in bipolar disorder and schizophrenia: effects of lifetime history of psychosis.
    Glahn DC; Bearden CE; Cakir S; Barrett JA; Najt P; Serap Monkul E; Maples N; Velligan DI; Soares JC
    Bipolar Disord; 2006 Apr; 8(2):117-23. PubMed ID: 16542181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociable mechanisms for memory impairment in bipolar disorder and schizophrenia.
    Glahn DC; Barrett J; Bearden CE; Mintz J; Green MF; Serap Monkul E; Najt P; Soares JC; Velligan DI
    Psychol Med; 2006 Aug; 36(8):1085-95. PubMed ID: 16734948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How common are psychotic and bipolar disorders? A 50-year follow-up of the Lundby population.
    Bogren M; Mattisson C; Isberg PE; Nettelbladt P
    Nord J Psychiatry; 2009; 63(4):336-46. PubMed ID: 19492244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders.
    Keck PE; Wilson DR; Strakowski SM; McElroy SL; Kizer DL; Balistreri TM; Holtman HM; DePriest M
    J Clin Psychiatry; 1995 Oct; 56(10):466-70. PubMed ID: 7559373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular disease and metabolic risk factors in male patients with schizophrenia, schizoaffective disorder, and bipolar disorder.
    Kilbourne AM; Brar JS; Drayer RA; Xu X; Post EP
    Psychosomatics; 2007; 48(5):412-7. PubMed ID: 17878500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P50 sensory gating deficit is a common marker of vulnerability to bipolar disorder and schizophrenia.
    Sánchez-Morla EM; García-Jiménez MA; Barabash A; Martínez-Vizcaíno V; Mena J; Cabranes-Díaz JA; Baca-Baldomero E; Santos JL
    Acta Psychiatr Scand; 2008 Apr; 117(4):313-8. PubMed ID: 18241306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of insight in patients with bipolar disorder: are self-rated scales developed for patients with schizophrenia applicable?
    Jónsdóttir H; Engh JA; Friis S; Birkenaes A; Ringen PA; Vaskinn A; Sundet K; Opjordsmoen S; Andreassen OA
    J Nerv Ment Dis; 2008 Apr; 196(4):333-5. PubMed ID: 18414129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clozapine in severe mood disorders.
    Zarate CA; Tohen M; Baldessarini RJ
    J Clin Psychiatry; 1995 Sep; 56(9):411-7. PubMed ID: 7665540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observations on the psychotomimetic effects of Sernyl.
    BAKKER CB; AMINI FB
    Compr Psychiatry; 1961 Oct; 2():269-80. PubMed ID: 13864199
    [No Abstract]   [Full Text] [Related]  

  • 18. Cognitive functioning of bipolar I patients and relatives from families with or without schizophrenia or schizoaffective disorder.
    Antila M; Partonen T; Kieseppä T; Suvisaari J; Eerola M; Lönnqvist J; Tuulio-Henriksson A
    J Affect Disord; 2009 Jul; 116(1-2):70-9. PubMed ID: 19117610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and length of hospital stay among older adults with bipolar disorder, schizophrenia or schizoaffective disorder, depression, and dementia.
    Sajatovic M; Friedman SH; Sabharwal J; Bingham CR
    J Geriatr Psychiatry Neurol; 2004 Mar; 17(1):3-8. PubMed ID: 15018690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical study of an anxiolytic antidepressive drug].
    Bolzani L; Slivar G
    Psychiatr Neurol (Basel); 1967; 153(5):301-7. PubMed ID: 5339994
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.